Tayyaba Hasan, PhD, is a professor of dermatology at Harvard Medical School and a professor of Health Sciences and Technology (Harvard-MIT). The focus of her research is in photochemical approaches to treatment and diagnosis of disease primarily in the areas of cancer and infections. She has over 281 publications and 23 inventions from research funded by the National Institutes of Health (NIH), the Department of Defense and Industry grants. Dr. Hasan leads a NCI funded multinational Program Project grant focused on image-guided treatment of pancreatic and skin cancers and an international consortium on developing low cost enabling technologies for image-guided photodynamic therapy of oral cancer. Dr. Hasan is an inventor of the FDA-approved photodynamic treatment of age-related macular degeneration and several other applications in fields of cancer, infections and technology.
Join via Zoom Password: CCGR
- The audience will learn about the fundamentals of photodynamic therapy.
- How the photodynamic therapy agents can be used in treatment monitoring and guided surgery.
- How the basic photochemical process primes the microenvironment at target sites and remotely.
- How the priming process can be exploited to enhance existing therapeutics.
- The special role that light can play in nanotechnology.
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.